FOLH1 and prostate cancer: Our second hypothesis is that PET/CT imaging targeting NTR1, GRPR, and PSMA could achieve non-invasive stratification of PCa-bearing models and prostate cancer lesions in vivo in patients, providing experimental and preliminary clinical data for non-invasive stratified diagnosis of PCa patients in the future.